Clinical Trial Update: Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Chronocort versus standard hydrocortisone replacement therapy in participants aged 16 years and older with congenital adrenal hyperplasi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Chronocort
• Hydrocortisone (standard replacement therapy) (hydrocortisone)

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Congenital Adrenal Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2025-02-24